MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 106 filers reported holding MEI PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $84,000 | -3.4% | 31,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $87,000 | +31.8% | 31,500 | +37.0% | 0.00% | 0.0% |
| Q2 2021 | $66,000 | -16.5% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $79,000 | +29.5% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $61,000 | -62.3% | 23,000 | -55.7% | 0.00% | -75.0% |
| Q3 2020 | $162,000 | +44.6% | 51,959 | +91.8% | 0.01% | +33.3% |
| Q2 2020 | $112,000 | +173.2% | 27,095 | +78.3% | 0.01% | +50.0% |
| Q3 2017 | $41,000 | -34.9% | 15,200 | -42.6% | 0.00% | -33.3% |
| Q2 2017 | $63,000 | +40.0% | 26,500 | -4.0% | 0.01% | +50.0% |
| Q1 2017 | $45,000 | +1400.0% | 27,600 | +1433.3% | 0.00% | – |
| Q3 2016 | $3,000 | – | 1,800 | +800.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 200 | -90.0% | 0.00% | -100.0% |
| Q1 2013 | $17,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |